 Phase: Phase IIType: BiomarkerLaboratory analysis, TreatmentStatus: ClosedAge: 18 and overSponsor: OtherProtocol IDs: CTRC 11-24, NCT01403610Phase: Phase IType: BiomarkerLaboratory analysis, TreatmentStatus: ClosedAge: 18 to 70Sponsor: Pharmaceutical IndustryProtocol IDs: EMR200592-007, 2013-003950-25, NCT02076230 